Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 7.50 (1.80%)
Spread: 10.00 (2.381%)
Open: 417.50
High: 425.00
Low: 417.50
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adaptix secures 510(k) clearance from FDA

30 Jan 2023 07:00

RNS Number : 1744O
Avingtrans PLC
30 January 2023
 

30 January 2023

Avingtrans Plc

 

("Avingtrans" or the "Group")

 

Adaptix secures 510(k) clearance from FDA

 

Avingtrans PLC (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that medical imaging technology associate company Adaptix Limited (Adaptix) has received 510(k) clearance from the U.S. Food and Drug Administration for its first orthopaedic medical imaging product.

 

In 2021, Avingtrans invested £4m in Adaptix, for an 11.9% stake in the business and in December 2022 announced a further investment of £2m by means of a Convertible Loan.

 

The Board of Adaptix has made the following announcement:

 

Adaptix, based at Oxford University Science Park, has received 510(k) clearance for its first medical imaging product. The first Adaptix medical product is a Digital Tomosynthesis Orthopaedic imaging system. It is a portable, low-dose imaging system capable of delivering fast, lower-cost, X-ray imaging at the point of patient care. Developed specifically to offer 3D X-ray imaging of hands, elbows and feet at a fraction of the radiation dose and per-study price of traditional CT systems, the system provides clinicians with clearer images than 2D X-ray systems, offering advantages in terms of fewer acquisitions, accelerated patient workflow and enhanced diagnostic accuracy.

 

Adaptix is already serving veterinary and industrial (Non-Destructive Evaluation) markets using its novel and patent-protected technologies. Receiving the 510(k) clearance is important as it is the first step in Adaptix delivering its mission to transform radiology through provision of innovative truly-portable 3D imaging technologies into healthcare providers.

 

Mark Evans, CEO of Adaptix, commented:

 

"We are delighted to receive the 510(k) clearance which allows this innovative technology, and our first medical product, to be marketed in the world's largest healthcare market. The team are energized by achieving this milestone, and we look forward to delivering enhanced orthopaedic DT imaging systems; a dental DT imaging system; and a chest DT imaging system for Intensive Care and Emergency Department use. We see a future where 3D travels to the patient at the point-of-care throughout hospitals, clinics and primary care transforming patient pathways, improving patient experience, and reducing the cost of care delivery."

 

Enquiries:

 

Avingtrans plc

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

01354 692391

Singer Capital Markets (Nominated Adviser and Broker)

Shaun Dobson

Alex Bond

Oliver Platts

 

02074 963000

IFC Advisory (Financial PR)

Graham Herring

Tim Metcalfe

Zach Cohen

020 3934 6630

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

 

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

 

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

 

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

 

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

 

Design, manufactures and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

 

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

 

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

 

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

 

Tecmag Inc, Houston, USA

 

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQKLFLXFLZBBE
Date   Source Headline
19th Aug 20117:00 amPRNNotice of Results
9th May 20119:00 amPRNHolding in Company
9th Mar 20117:00 amPRNTR-1:Notification of Major Interest in Shares
21st Feb 20117:00 amPRNGBP5m Contract Extension for Aerospace Division
9th Feb 20117:00 amRNSInterim Statement
17th Jan 20117:01 amPRNEUR 2.2m Contract Win
17th Jan 20117:00 amPRNTrading Statement
8th Dec 20101:38 pmRNSCorrection-Director/PDMR Shareholding
8th Dec 201010:27 amRNSHolding(s) in Company
8th Dec 201010:25 amRNSDirector/PDMR Shareholding
9th Nov 201011:44 amRNSHolding(s) in Company
13th Oct 201011:35 amRNSResult of AGM 2010
24th Sep 20101:00 pmPRNDirector/PDMR Shareholding
24th Sep 201012:09 pmPRNGrant of Options
8th Sep 20107:00 amPRNFinal Results
7th Sep 20107:00 amPRNAerospace Contract Wins
6th Sep 20107:00 amPRNContract Win
26th Jul 20107:00 amPRNChange of Adviser
7th Jul 201010:13 amPRNHolding(s) in Company
2nd Jul 20107:00 amRNSContract Win
15th Jun 20107:00 amPRNTrading Update
1st Apr 20107:00 amPRNGBP8m Contract Win and Award Win
19th Mar 20102:52 pmPRNDirector/PDMR Shareholding
19th Mar 20107:00 amPRNTrading Statement
17th Mar 20107:30 amPRNHolding(s) in Company
18th Feb 201011:28 amPRNHolding(s) in Company
10th Feb 20102:59 pmPRNDirector/PDMR Shareholding
10th Feb 20107:00 amPRNHalf-yearly Report
27th Jan 20107:00 amPRNContract Win - Aerospace Division
15th Oct 200910:56 amPRNResult of AGM
6th Oct 20097:00 amRNSNew Contract Award
9th Sep 20097:03 amPRNDirectorate Change
9th Sep 20097:00 amPRNFinal Results
11th Aug 20097:00 amRNSContract Extension
5th Aug 20099:14 amRNSNotice of Results
17th Jul 20093:01 pmRNSSettlement of Claim
8th Jul 20093:10 pmRNSGrant of Options
7th Jul 20095:03 pmRNSTotal Voting Rights
8th Jun 200912:48 pmRNSHolding(s) in Company
29th May 20097:00 amRNSAdditional Listing
27th Apr 200910:48 amRNSDirector/PDMR Shareholding
10th Feb 20097:00 amRNSHalf Yearly Report
6th Feb 20097:00 amRNSNotice of Results
26th Jan 20097:00 amRNSContract Win
31st Oct 20087:00 amRNSTotal Voting Rights
22nd Oct 20083:13 pmRNSHolding(s) in Company
22nd Oct 20083:07 pmRNSHolding(s) in Company
22nd Oct 20083:01 pmRNSHolding(s) in Company
22nd Oct 20082:18 pmRNSHolding(s) in Company
20th Oct 20083:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.